Hhs

• A proposed White House Office of Management and Budget (OMB) rule threatens research by using PEPFAR as a justification to increase political oversight of federal grantmaking. • Vaccine development is accelerating in response to the growing Ebola Bundibugyo outbreak to mitigate the spread of the virus. • The US Secretary of State is facing questioning from multiple Congressional committees regarding the future and strategic direction of PEPFAR.

Serious side effects from vaccines were rare, scientists found in studies funded by US taxpayer moneyThe US Food and Drug Administration has blocked the publication of several studies that found Covid-19 and shingles vaccines to be safe, according to a spokesperson from the Department of Health and Human Services.Agency scientists conducted the studies by analyzing millions of patient records and found that serious side effects from the vaccines were rare, the spokesperson confirmed. The studies – funded by taxpayer money and costing several million dollars – included research examining the safety of Covid-19 vaccines in 2023 and 2024. Continue reading...

• The Trump administration's Department of Health and Human Services notified hospitals and nursing homes on May 4, 2026, to prioritize 'real food' over sugary drinks and dietary supplements in patient meals. • The policy shift faced immediate backlash from healthcare providers concerned about implementation and patient preferences. • This agenda aims to combat diet-related diseases amid rising obesity rates, potentially affecting millions of inpatients annually.

• HHS launched the $4 Million KidneyX EMPOWER Prize Challenge on April 15, 2026, to advance living kidney donation and patient-centered health technologies. • The initiative aims to spur innovation in kidney care through science and programs improving American health outcomes. • This effort addresses critical needs in organ transplantation, potentially increasing donation rates and access to treatments.

• HHS issued a final rule on April 7, 2026, permanently extending Medicare telehealth flexibilities introduced during COVID-19, covering 85 million Medicaid enrollees. • Audio-only visits now reimbursable at $18-$40 per session, with $37 billion allocated through 2030 to rural providers. • Addresses access gaps in 20% of US counties lacking specialists; 'This bridges urban-rural divides,' said HHS Secretary.

• HHS and CMS announced new members for the Healthcare Advisory Committee on March 27, 2026, to enhance patient care and modernize U.S. healthcare. • Committee focuses on policy recommendations for efficiency, innovation, and better outcomes nationwide. • Initiative aims to address systemic challenges amid evolving public health needs.

• HHS through the National Cancer Institute announced a $200 million public-private partnership to fund clinical trials for cancer vaccines targeting high-risk recurrence patients. • The initiative supports mRNA and other vaccine types, aiming to accelerate development with private sector involvement including venture capital. • 'Nothing of this scale has been attempted in cancer vaccines before,' said Stacey Adam, VP of science partnerships for the Foundation for the National Institutes of Health.

• The Department of Health and Human Services announced expanded telehealth reimbursement policies effective immediately, allowing federally qualified health centers in rural areas to bill for remote patient monitoring services at 80% of in-person rates. • The rule change aims to address healthcare disparities in 60 million rural Americans by enabling chronic disease management and specialist consultations without travel barriers, with CMS projecting 2.3 million rural patients will gain access to remote care. • Studies show telehealth reduces healthcare costs by 15-20% while maintaining clinical quality, with rural adoption rates currently at 12% compared to 38% in urban areas.

• A federal judge in Oregon ruled on March 20, 2026, that the U.S. Department of Health and Human Services under Secretary Robert F. Kennedy Jr. overreached by issuing a December declaration labeling puberty blockers and surgeries for gender dysphoria as unsafe without proper procedures. • The declaration warned doctors of exclusion from Medicare and Medicaid for providing such treatments, prompting a lawsuit led by New York Attorney General Letitia James alleging coercion and lack of public notice or comment period. • The ruling provides legal clarity for patients, families, and providers, affirming that transgender health services remain available despite major medical groups like the AMA opposing restrictions.

• Trump 2.0 policies terminated or overhauled HHS advisory committees, including ACIP with all members replaced in January 2026 by RFK Jr., leading to weakened hepatitis B and COVID-19 vaccine recommendations. • NIH advisory councils have not met, with the director's committee disbanded for over a year; USPSTF has not met since March 2025. • Senator Murray criticized leadership for prohibiting NIH grant processes; new ACIP includes controversial figures like an Alzheimer's patient from the withdrawn aducanumab trial.